T1aN0M0 and T1bN0M0 non-small cell lung cancer: A retrospective study of the prognosis

Thoracic and Cardiovascular Surgeon

Volumn 62, Issue 2, 2014, Pages 109-116

  Zhang, Zhenfa ^a   Wang, Anlei ^a   Zhan, Zhongli ^a   Sun, Leina ^a   Chen, Kexin ^a   Wang, Changli ^a  

^a Lung Tumor Department of the Affiliated Cancer Hospital of Tian Jin Medical University   (China)

Author keywords

non small cell lung cancer; prognosis; T1aN0M0; T1bN0M0

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR INVASION; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; COMPUTER ASSISTED TOMOGRAPHY; EPIDEMIOLOGY; FOLLOW UP; LUNG NEOPLASMS; LUNG RESECTION; MEDIASTINOSCOPY; MORTALITY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; TIME; TRENDS;

BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84897024939     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0032-1329191     Document Type: Article

References (28)

1. López-Encuentra A., Duque-Medina J. L., Rami-Porta R., de la Cámara A. G., Ferrando P. Bronchogenic Carcinoma Co-operative Group of the Spanish Society of Pneumology and Thoracic Surgery Staging in lung cancer: is 3 cm a prognostic threshold in pathologic stage I non-small cell lung cancer? A multicenter study of 1,020 patients. Chest: 2002; 121 5 1515 1520
2. Wisnivesky J. P., Yankelevitz D., Henschke C. I. The effect of tumor size on curability of stage I non-small cell lung cancers. Chest: 2004; 126 3 761 765
3. Mery C. M., Pappas A. N., Burt B. M., et al. Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage. Chest: 2005; 128 5 3255 3260
4. Agarwal M., Brahmanday G., Chmielewski G. W., Welsh R. J., Ravikrishnan K. P. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection. Lung Cancer: 2010; 68 3 398 402
5. UICC International Union Against Cancer Lung and pleural tumors. In: Sobin L. H., Gospodarowicz M. K., Wittekind C., eds. TNM Classification of Malignant Tumors. 7th ed. Oxford, England Wiley-Blackwell: 2009; 138 146
6. Goldstraw P. The 7th edition of TNM in lung cancer: what now? J Thorac Oncol: 2009; 4 6 671 673
7. Patz E. F. Jr, Rossi S., Harpole D. H. Jr, Herndon J. E., Goodman P. C. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest: 2000; 117 6 1568 1571
8. Yanagi S., Sugiura H., Morikawa T., et al. Tumor size does not have prognostic significance in stage IA NSCLC. Anticancer Res: 2000; 20 2B 1155 1158
9. Ye C., Masterman J. R., Huberman M. S., et al. Subdivision of the T1 size descriptor for stage I non-small cell lung cancer has prognostic value: a single institution experience. Chest: 2009; 136 3 710 715
10. Rusch V. W., Asamura H., Watanabe H., Giroux D. J., Rami-Porta R., Goldstraw P. Members of IASLC Staging Committee The IASLC Lung Cancer Staging Project: A proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol: 2009; 4 568 577
11. Zhang Z., Xu F., Wang S., Li N., Wang C. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer. Lung Cancer: 2008; 60 3 434 440
12. Mountain C. F., Carr D. T., Anderson W. AD. A system for the clinical staging of lung cancer. Am J Roentgenol Radium Ther Nucl Med: 1974; 120 1 130 138
13. Flieder D. B., Port J. L., Korst R. J., et al. Tumor size is a determinant of stage distribution in T1 non-small cell lung cancer. Chest: 2005; 128 4 2304 2308
14. Chang M. Y., Mentzer S. J., Colson Y. L., et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg: 2007; 134 4 850 856
15. Christian C., Erica S., Morandi U. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification. Lung Cancer: 2006; 54 2 185 191
16. Goldstraw P., Crowley J., Chansky K., et al. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol: 2007; 2 8 706 714
17. Rami-Porta R., Ball D., Crowley J. J., et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol: 2007; 2 7 593 602
18. Postmus P. E., Brambilla E., Chansky K., et al. International Association for the Study of Lung Cancer International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol: 2007; 2 8 686 693
19. Maeda R., Yoshida J., Ishii G., et al. Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension. Chest: 2010; 138 2 357 362
20. Suzuki K., Nagai K., Yoshida J. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer: 1999; 86 10 1976 1984
21. Miyoshi K., Moriyama S., Kunitomo T., Nawa S. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer. J Thorac Cardiovasc Surg: 2009; 137 2 429 434
22. Naruke T. Significance of lymph node metastases in lung cancer. Semin Thorac Cardiovasc Surg: 1993; 5 3 210 218
23. Izbicki J. R., Passlick B., Pantel K., et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg: 1998; 227 1 138 144
24. Gajra A., Newman N., Gamble G. P., Kohman L. J., Graziano S. L. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol: 2003; 21 6 1029 1034
25. Wu Y. C., Lin C-FJ, Hsu W. H., Huang B. S., Huang M. H., Wang L. S. Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardiothorac Surg: 2003; 24 6 994 1001
26. Ou S. H., Zell J. A. Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer. J Thorac Oncol: 2008; 3 8 880 886
27. Izbicki J. R., Passlick B., Hosch S. B., et al. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg: 1996; 112 3 623 630
28. Gu C. D., Osaki T., Oyama T., et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival. Ann Surg: 2002; 235 1 133 139